Skip to Content
مبادرة سورية المستقبل
  • Home
  • Meet Us
  • Join Us
  •  Contact Us
  • الْعَرَبيّة English (US) Français Deutsch
  • Follow us
مبادرة سورية المستقبل
      • Home
      • Meet Us
      • Join Us
    • Follow us
    • الْعَرَبيّة English (US) Français Deutsch
    •  Contact Us

    Dr. Mahmoud Halima


    • PhD in Immuno-pharmacology from Leiden University, Netherlands.

    • Project Manager at Leiden University and Hospital, and the Chinese-European Institute for Drug Discovery and Development.

    • CEO of Ultra Group in Turkey for International Industries.

    • CEO of Ultra Biomed in the Netherlands.

    • Consultant at Neta Pharm for Pharmaceutical Industries.

    • Former Head of the Drug Laboratory at the Center for Scientific Studies and Research.

    • Bachelor's degree in Veterinary Medicine and Surgery (2003).

    • Master's degree in Biomedical Medicine (2018).

    • PhD in Immunology from Leiden University (2022).

    Key Achievements:

    • Five patents: three national and two international in the field of drug development.
    • Development of an antidote for snake venom.
    • Development of an antidote for scorpion venom.
    • Development of an antidote for nerve gases and chemical weapons.
    • Development of treatments for complex autoimmune diseases.
    • Development of a treatment for eye cancer.

    Years of Experience: 22 years.

     

    A group of Syrians, including university professors, academics, consultants, and project managers, who have worked abroad.

    We use cookies to provide you a better user experience on this website. Cookie Policy

    Only essentials I agree